• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Asthma and Being Female

Slideshow

Early menarche, irregular menstruation, menopause onset, and HRT – especially estrogen-only HRT: all appear to be linked with an increased risk of asthma.

Increased risk of asthma risk appears to be linked to early menarche, irregular menstruation, menopause onset, and HRT – especially estrogen-only HRT. Details here from the most comprehensive meta-analysis of asthma in females to date.

References:

1. Nwaru BI, Nurmatov U, Sheikh A. Endogenous and exogenous sex steroid hormones in asthma and allergy in females: protocol for a systematic review and meta-analysis. NPJ Prim Care Respir Med. 2016; 26:15078. https://www.ncbi.nlm.nih.gov/pubmed/268206442. Lieberoth S, Gade EJ, Brok J, et al. Age at menarche and risk of asthma: systematic review and meta-analysis. J Asthma. 2014; 51:559-565. 3. Zemp E, Schikowski T, Dratva J, et al. Asthma and the menopause: a systematic review and meta-analysis. Maturitas. 2012; 73:212-217.4. McCleary N, Nwaru BI, Nurmatov UB, et al. Endogenous and exogenous sex steroid hormones in asthma and allergy in females: a systematic review and meta-analysis. J Allergy Clin Immunol. 2018 Jan 2. pii: S0091-6749(17)33009-9. doi: 10.1016/j.jaci.2017.11.034 https://www.ncbi.nlm.nih.gov/pubmed/29305316

Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
© 2024 MJH Life Sciences

All rights reserved.